Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion

Keisuke Tonouchi1,2, Yu Adachi1, Tateki Suzuki3

  • 1Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan.

Plos Pathogens
|August 9, 2023
PubMed